The Jan Grimm Lab

The Grimm lab in the Molecular Pharmacology Program focuses on the development of novel and innovative molecular imaging approaches for cancer diagnostics, predominantly based on activatable imaging agents. These approaches combine and utilize modern biology, nanotechnology, chemistry and physics with modern imaging methods (MRI, optical imaging, PET and Cerenkov) to create novel imaging agents that allow much earlier detection and improved therapy monitoring of cancer.

Learn more
Jan Grimm, MD, PhD

Jan Grimm, MD, PhD

Associate Professor

Research Focus

Radiologist Jan Grimm develops novel activatable molecular imaging approaches for improved detection and monitoring of prostate and other cancers.


  • MD, University of Hamburg (Germany)
  • PhD, University of Kiel (Germany)

Selected Achievements

  • 2014- NIH Nagy New Investigator Award
  • 2018- The American Society for Clinical Investigation (ASCI) Member